Par Specialty Pharmaceuticals (formerly called Strativa Pharmaceuticals) has launched a single use version of Nascobal cyanocobalamin nasal spray for the treatment of pernicious anemia and other vitamin B12 deficiencies, the company said. The FDA approved the single dose, once-a-week product, which is packaged in cartons of four, in June 2014.
The company also announced a program called Nascobal Nutrition Direct which provides home delivery of a package of supplements, including Nascobal nasal spray, to bariatric surgery patients.
Par Specialty Pharmaceuticals Senior VP, Brand Sales and Marketing, Rick Painter commented, “Our newly available Nascobal single-use device does not require priming, which eliminates product loss. Along with Nascobal, we are proud to offer patients Nascobal Nutrition Direct. Following bariatric surgery, Nascobal Nutrition Direct allows physicians to help their patients receive lifelong integrated nutritional support as simply as possible.”
According to the company, it “is continuing the development of new and enhanced versions of Nascobal in order to better meet the needs of those patients who rely upon the product.”
Read the Par Pharmaceuticals press release.
